Oral controlled-release dosage forms .1. Cellulose ether polymers in hydrophilic matrices

被引：91

作者：

Salsa, T ^{[1
]}

Veiga, F ^{[1
]}

Pina, ME ^{[1
]}

机构：

[1] UNIV COIMBRA,FAC PHARM,LAB GALEN & PHARMACEUT TECHNOL,P-3049 COIMBRA,PORTUGAL

来源：

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1997年 / 23卷 / 09期

关键词：

controlled-release matrices; hydrophilic matrices; cellulose ether polymers; hydroxypropylmethylcellulose; HPMC;

D O I：

10.3109/03639049709148697

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

An appropriately designed controlled-release drug delivery system can be a major advance towards solving problems concerning the targeting of a drug to a specific organ or tissue and controlling the rate of drug delivery to the target tissue. Hydrophilic matrices are an interesting option when developing cut oral controlled-release formulation. The present study focuses on oral controlled-release dosage forms and the application of cellulose ether polymers in hydrophilic matrices.

引用

页码：929 / 938

页数：10

共 90 条

[1] EVALUATION OF SOLUBILIZERS IN THE DRUG-RELEASE TESTING OF HYDROPHILIC MATRIX EXTENDED-RELEASE TABLETS OF FELODIPINE [J].

ABRAHAMSSON, B ;

JOHANSSON, D ;

TORSTENSSON, A ;

WINGSTRAND, K .

PHARMACEUTICAL RESEARCH, 1994, 11 (08) :1093-1097

[2]

ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1

[3]

AVAN JL, 1985, STP PHARM, V1, P516

[4] PHYSICAL MODEL FOR RELEASE OF DRUG FROM GELFORMING SUSTAINED-RELEASE PREPARATIONS [J].

BAMBA, M ;

PUISIEUX, F ;

MARTY, JP ;

CARSTENSEN, JT .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1979, 3 (2-3) :87-92

[5] RELEASE MECHANISMS IN GELFORMING SUSTAINED-RELEASE PREPARATIONS [J].

BAMBA, M ;

PUISIEUX, F ;

MARTY, JP ;

CARSTENSEN, JT .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1979, 2 (5-6) :307-315

[6] RELEASE CHARACTERISTICS OF SOME BRONCHODILATORS FROM COMPRESSED HYDROPHILIC POLYMERIC MATRICES AND THEIR CORRELATION WITH MOLECULAR-GEOMETRY [J].

BAVEJA, SK ;

RAO, KVR ;

SINGH, A ;

GOMBAR, VK .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 41 (1-2) :55-62

[7]

BONFERONI MC, 1995, EUR J PHARM BIOPHARM, V41, P242

[8]

BURI P, 1980, PHARM ACTA HELV, V55, P189

[9]

BURI P, 1981, LABOPHARM PROB TECH, V307, P181

[10]

BURI P, 1987, STP PHARM, V3, P193

← 1 2 3 4 5 6 7 8 9 →